GAO to investigate FDA approval process

03/4/2008 | San Diego Union-Tribune

The Government Accountability Office has agreed to investigate the FDA's drug-approval process, which cleared the drugs Vytorin and Avandia despite concerns over their safety and efficacy. One question facing the GAO is whether the agency should rely on biological measures -- such as cholesterol and blood-sugar levels -- if it lacks proof that the treatment can improve more important outcomes, such as patient survival.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD